Insider Transactions in Q2 2021 at Athenex, Inc. (ATNX)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 07
2021
|
John Vierling Director |
BUY
Open market or private purchase
|
Direct |
250
+6.25%
|
$1,000
$4.5 P/Share
|
|
May 07
2021
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+0.15%
|
$20,000
$4.55 P/Share
|
|
May 07
2021
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,000
+12.52%
|
$96,000
$4.55 P/Share
|
|
May 06
2021
|
John Vierling Director |
BUY
Open market or private purchase
|
Direct |
1,700
+32.69%
|
$6,800
$4.04 P/Share
|
|
May 06
2021
|
Kim Campbell Director |
BUY
Open market or private purchase
|
Direct |
1,750
+14.89%
|
$7,000
$4.03 P/Share
|
|
May 06
2021
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Open market or private purchase
|
Direct |
5,000
+0.15%
|
$15,000
$3.99 P/Share
|
|
May 05
2021
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+0.77%
|
$100,000
$4.55 P/Share
|
|
May 05
2021
|
Jinn Wu Director |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+6.6%
|
$200,000
$4.55 P/Share
|
|
Apr 05
2021
|
Kim Campbell Director |
BUY
Open market or private purchase
|
Direct |
8,250
+50.0%
|
$33,000
$4.42 P/Share
|